Indication
Discoid lupus erythematosus
Discoid lupus erythematosus is a chronic autoimmune dermatologic condition representing the most common subtype of chronic cutaneous lupus erythematosus. Read more about Discoid lupus erythematosus
770 drugs 211 manufacturers
Drugs that treat it
Common Discoid lupus erythematosus therapies.
DESOXIMETASONE
HYDROXYCHLOROQUINE SULFATE
DESONIDE
DESONIDE
PREDNICARBATE
PSORCON (diflorasone diacetate)
PREPARATION H (hydrocortisone)
DERMAWERX SDS (triamcinolone acetonide/dimethicone/silicone, adhesive)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiscoid lupus erythematosus is a chronic autoimmune dermatologic condition representing the most common subtype of chronic cutaneous lupus erythematosus.
It predominantly affects the integumentary system—most often appearing in women on sun-exposed regions such as the scalp, face, and ears—either as an isolated cutaneous disease or as a cutaneous manifestation of systemic lupus erythematosus.
Pathophysiologically, localized interface dermatitis and autoimmune inflammation produce well-demarcated, disc-shaped erythematous plaques that display adherent follicular hyperkeratotic scaling and telangiectasias, which classically evolve over time into cutaneous atrophy, dyspigmentation, scarring, and permanent scarring alopecia.
- nih.gov
Discoid lupus erythematosus is a chronic autoimmune dermatologic condition representing the most common subtype of chronic cutaneous lupus erythematosus It predominantly affects the integumentary system—most often appearing in women on sun-exposed regions such as the scalp, face, and ears—either as an isolated cutaneous disease or as a cutaneous manifestation of systemic lupus erythematosus Pathophysiologically, localized interface dermatitis and autoimmune inflammation produce well-demarcated, ...
- nih.gov
Discoid lupus erythematosus is a chronic autoimmune dermatologic condition representing the most common subtype of chronic cutaneous lupus erythematosus Pathophysiologically, localized interface dermatitis and autoimmune inflammation produce well-demarcated, disc-shaped erythematous plaques that display adherent follicular hyperkeratotic scaling and telangiectasias, which classically evolve over time into cutaneous atrophy, dyspigmentation, scarring, and permanent scarring alopecia
- medlineplus.gov
It predominantly affects the integumentary system—most often appearing in women on sun-exposed regions such as the scalp, face, and ears—either as an isolated cutaneous disease or as a cutaneous manifestation of systemic lupus erythematosus
- medlineplus.gov
It predominantly affects the integumentary system—most often appearing in women on sun-exposed regions such as the scalp, face, and ears—either as an isolated cutaneous disease or as a cutaneous manifestation of systemic lupus erythematosus
- nih.gov
Pathophysiologically, localized interface dermatitis and autoimmune inflammation produce well-demarcated, disc-shaped erythematous plaques that display adherent follicular hyperkeratotic scaling and telangiectasias, which classically evolve over time into cutaneous atrophy, dyspigmentation, scarring, and permanent scarring alopecia
- nih.gov
Pathophysiologically, localized interface dermatitis and autoimmune inflammation produce well-demarcated, disc-shaped erythematous plaques that display adherent follicular hyperkeratotic scaling and telangiectasias, which classically evolve over time into cutaneous atrophy, dyspigmentation, scarring, and permanent scarring alopecia
Personalize your experience
Follow Discoid lupus erythematosus and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.